Konark Invacare Private Limited

Konark Invacare Private Limited

Pharmaceutical company specializing in manufacturing, importing, and exporting various healthcare products.
2017 | Thane, Maharashtra (India) | Active

Last Updated:

December 08, 2024
HomeCompanyKonark Invacare Private Limited

Who are the key members and board of directors at Konark Invacare?

Board Members(4)

NameDesignationAppointment DateStatus
Swapnil Harne In Director 12-Oct-2017Current
Shubham Harne In Director 12-Oct-2017Current
Mahendra Harne In Director 12-Oct-2017Current
Rama Harne In Director 12-Oct-2017Current

Financial Performance of Konark Invacare.

Konark Invacare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 76.8% increase. The company also saw a substantial improvement in profitability, with a 1660.18% increase in profit. The company's net worth Soared by an impressive increase of 132.05%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
76.80%
Revenue from Operations
76.80%
Total Assets
72.64%
Profit or Loss
1660.18%
Net Worth
132.05%
EBITDA
9858.46%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Konark Invacare?

Unlock and access historical data on people associated with Konark Invacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Konark Invacare

Recent activity within the organization

  • Annual General Meeting

    Konark Invacare Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Konark Invacare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Director Appointment

    Swapnil Mahendra Harne was appointed as a Director was appointed as a Director on 12 Oct 2017 & has been associated with this company since 7 years 3 months .

    12 Oct 2017

  • Director Appointment

    Shubham Harne was appointed as a Director was appointed as a Director on 12 Oct 2017 & has been associated with this company since 7 years 3 months .

    12 Oct 2017

  • Director Appointment

    Mahendra Kashiram Harne was appointed as a Director was appointed as a Director on 12 Oct 2017 & has been associated with this company since 7 years 3 months .

    12 Oct 2017

  • Director Appointment

    Rama Mahendra Harne was appointed as a Director was appointed as a Director on 12 Oct 2017 & has been associated with this company since 7 years 3 months .

    12 Oct 2017

Frequently asked questions

  • Konark Invacare Private Limited was incorporated on 12 Oct 2017.

  • The authorized share capital of Konark Invacare Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.

  • Currently 4 directors are associated with Konark Invacare Private Limited.

    • Swapnil Mahendra Harne
    • Shubham Harne
    • Mahendra Kashiram Harne
    • Rama Mahendra Harne
  • As per Ministry of Corporate Affairs (Mca), the registered address of Konark Invacare Private Limited is Office No. 401 Unique Complex Off Ghodbunder Road Opposite Tmc Commissioner Bungalow, Patl Ipada India, Thane West, Maharashtra, 400607.

  • The corporate identification number (CIN) of Konark Invacare Private Limited is U74999MH2017PTC300740 and the company number is 300740 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2020, the revenue trend for Konark Invacare Private Limited has risen by 76.80%.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Konark Invacare Private Limited has experienced an upsurge of 132.05%.

  • The most recent Balance Sheet for Konark Invacare Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Drug Formulation & Development